The genetic contribution to a number of neurological disorders is thought to be complex in nature, disease risk being driven by a combination of risk alleles commonly present in the human genome. Recently the completion of stages I and II of the international Haplotype Map project and the availability of high-plex SNP assays has made genome wide assay of common genetic variability a realistic endeavor. We have applied genome wide association analysis using 500,000SNPs to a Parkinsons disease cohort from the NIH funded neurogenetics repository. We have combined the data from this work with collaborators from Germany, the US, the UK and Japan. This work has lead to the identification of common variability in SNCA and MAPT as unequivocal risk factors for Parkinson's disease. Further this work has identified a novel locus on chromosome 1 as a risk factor for PD. We have now extended this work and combined results with other large genotyping projects in PD and related diseases to identify additional risk loci for this disease, identifying an additional 7-10 risk loci for Parkinson's disease. We plan to follow this with replication genotyping and resequencing to nominate common and rare risk variants in these diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIAAG000949-05
Application #
8148360
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2010
Total Cost
$349,590
Indirect Cost
Name
National Institute on Aging
Department
Type
DUNS #
City
State
Country
Zip Code
Burciu, Roxana G; Seidler, Rachael D; Shukla, Priyank et al. (2018) Multimodal neuroimaging and behavioral assessment of ?-synuclein polymorphism rs356219 in older adults. Neurobiol Aging 66:32-39
Billingsley, K J; Bandres-Ciga, S; Saez-Atienzar, S et al. (2018) Genetic risk factors in Parkinson's disease. Cell Tissue Res 373:9-20
Blauwendraat, Cornelis; Kia, Demis A; Pihlstrøm, Lasse et al. (2018) Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's disease. Neurobiol Aging 64:159.e5-159.e8
Marioni, Riccardo E; McRae, Allan F; Bressler, Jan et al. (2018) Meta-analysis of epigenome-wide association studies of cognitive abilities. Mol Psychiatry 23:2133-2144
Mollenhauer, Brit; Caspell-Garcia, Chelsea J; Coffey, Christopher S et al. (2017) Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls. Neurology 89:1959-1969
Capozzo, Rosa; Sassi, Celeste; Hammer, Monia B et al. (2017) Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy. Alzheimers Dement 13:858-869
Noyce, Alastair J; Kia, Demis A; Hemani, Gibran et al. (2017) Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study. PLoS Med 14:e1002314
Hammer, Monia B; Ding, Jinhui; Mochel, Fanny et al. (2017) SLC25A46 Mutations Associated with Autosomal Recessive Cerebellar Ataxia in North African Families. Neurodegener Dis 17:208-212
Blauwendraat, Cornelis; Faghri, Faraz; Pihlstrom, Lasse et al. (2017) NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases. Neurobiol Aging 57:247.e9-247.e13
Larsson, Susanna C; Singleton, Andrew B; Nalls, Mike A et al. (2017) No clear support for a role for vitamin D in Parkinson's disease: A Mendelian randomization study. Mov Disord 32:1249-1252

Showing the most recent 10 out of 83 publications